Asthma paradoxes: time for a new approach across the spectrum of asthma severity

We support the proposal that anti-inflammatory reliever therapy replaces the current use of short-acting β 2 -agonist reliever therapy in adults across the range of asthma severity http://ow.ly/uUtP30nHqhj